Month: April 2025

ATTENTION-AD trial data through 192 weeks presented at AD/PDTM 2025 Conference Prespecified delayed-start analysis indicate disease-modifying effect of oral blarcamesine and importance of early and continued long-term treatment of chronic Alzheimer’s disease Blarcamesine exhibited a favorable safety profile with no treatment-related deaths NEW YORK, April 05, 2025 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that over three years of continuous treatment with blarcamesine (ANAVEX®2-73)...

The Board of Golden Ocean Group Ltd. (“Golden Ocean” or the “Company”) is pleased to announce the appointment of Mr. Peder Simonsen as the Chief Executive Officer of Golden Ocean Management AS. Mr. Simonsen currently serves as the Interim Chief Executive Officer and Chief Financial Officer of Golden Ocean Management AS. Further, the Company is pleased to announce the appointment of Ms. Randi Navdal Bekkelund as Chief Financial Officer of Golden Ocean Management. Ms. Bekkelund currently serves as the Chief Financial Officer of Avance Gas Holding Ltd. Ms. Bekkelund will commence her new role on June 1, 2025. April 5, 2025 The Board of DirectorsGolden Ocean Group Ltd.Hamilton, Bermuda This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.  

New Data Demonstrate Proportion of Corrected M-AAT Reached a Mean of 91% of Total AAT in Circulation at Day 28 Following BEAM-302 Treatment in 60 mg Cohort (n=3) Mean Decrease of 79% in Mutant Z-AAT Observed at Day 28 in 60 mg Cohort (n=3) Fourth Cohort Evaluating 75 mg of BEAM-302 Initiated, with Updated Data from Part A of the Phase 1/2 Trial Expected to be Presented at a Medical Conference in Second Half of 2025 CAMBRIDGE, Mass., April 05, 2025 (GLOBE NEWSWIRE) —  Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today presented additional data from the Phase 1/2 clinical trial of BEAM-302 in patients with alpha-1 antitrypsin deficiency (AATD) at the 2025 Alpha-1 Foundation 7th Global Research Conference and 10th Patient Congress, taking place April 4-5,...

CALHOUN, Ga., April 04, 2025 (GLOBE NEWSWIRE) — In conjunction with Mohawk Industries’ (NYSE: MHK) First Quarter 2025 earnings release on Thursday, May 1, 2025, you are invited to listen to the conference call that will be broadcast live on Friday, May 2, 2025, at 11:00 am ET.     What:   Mohawk Industries’ First Quarter Earnings Call     When:   May 2, 2025    11:00 am ET     Where:   www.mohawkind.com     Select “Investors” tab     How:   Live over the Internet – Simply log on via the web at the address above or    Register for the conference call at: https://dpregister.com/sreg/10198186/feca56553a    Live Conference Call: Dial 1-833-630-1962 (U.S./Canada)      Dial 1-412-317-1843 (International)     For those unable to listen at the designated time, the call will remain available...

TORONTO, April 04, 2025 (GLOBE NEWSWIRE) — Partners Value Split Corp. (the “Company”) announced today its intention to redeem all of its 6,000,000 outstanding Class AA Preferred Shares, Series 11 (“Preferred Shares, Series 11”) for cash on April 22, 2025 (the “Redemption Date”) in accordance with the terms of the Preferred Shares, Series 11. The redemption price per Preferred Share, Series 11 will be equal to C$25.00 per share plus accrued and unpaid dividends of C$0.17 per share to April 21, 2025, representing a total redemption price of C$25.17 per share (the “Redemption Price”). Notice has been delivered to holders of the Preferred Shares, Series 11 in accordance with the terms of the Preferred Shares, Series 11. From and after the Redemption Date, the Preferred Shares, Series 11 will cease to be entitled to dividends or any...

Amesite’s U.S. Workforce, Technology and Customers Insulate Company from Trade Uncertainties; Cost Concerns Drive Amesite Sales Growth DETROIT, April 04, 2025 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today confirms that its operations remain unaffected by recently announced U.S. tariffs. Amesite is U.S.-owned with a fully remote, U.S.-based workforce and no reliance on foreign hardware or suppliers. Amesite’s cloud-native infrastructure avoids international chokepoints, shielding it from tariff impacts. Software companies and platforms built on domestic technology and workforces remain insulated from the newly implemented trade policy, which sets a 10% tariff on most imports—and up to 32% on goods from certain countries. Amesite CEO, Dr. Ann Marie Sastry, said, “Our...

SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) — Beam Global, (Nasdaq: BEEM), (the “Company”), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation and energy security, today announced that it will report its 2024 operating results on Friday, April 11, 2025 after the market closes. Management will host a conference call on Friday, April 11, 2025 at 4:30 p.m. ET to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question-and-answer session. Conference call details: Date:   April 11, 2025 Time: 4:30 p.m. Eastern / 1:30 p.m. PacificToll-Free Dial-In Number:   1-844-739-3880    International Dial-In Number:   1-412-317-5716 Pre-register for the call through this link:  https://dpregister.com/sreg/10198405/fed880d536 All...

ORLANDO, Fla., April 04, 2025 (GLOBE NEWSWIRE) — Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it has signed an Associate Partnership agreement with Charlotte FC. The Company intends to use the Associate partnership to build visibility for its brands such as AI Tape which is manufactured locally in the Charlotte area. “We are very excited to partner with an organization such as Charlotte FC as an Associate Partner. Manufacturing many of our products locally in the Charlotte region through our Pocono subsidiary makes this relationship special.’’ AI Tape is manufactured in the USA at the Company’s Pocono Pharmaceutical facility in North Carolina. The Company also intends to use the relationship to promote its platform technology AVERSA and...

TORONTO, April 04, 2025 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) has nominated Ben van Beurden and Pekka Vauramo for election to its Board of Directors at the company’s Annual and Special Meeting of Shareholders on May 6, 2025. Ben van Beurden, former chief executive of Shell, brings four decades of global experience in the energy and natural resources sectors. At Shell, he led the company’s strategic transformation from an oil-focused business to a diversified energy leader, with a strong emphasis on natural gas and renewable energy investments. This transformation placed Shell among the top quartile of investors in energy transition. Mr. van Beurden is recognized for his strategic decision to simplify Shell’s shareholding structure and consolidate the company’s headquarters in London, benefiting...